Ketorolac Tromethamine Injection, Solution
Product Images NDC 31722-306

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 31722-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolacinj15mg1mlcarton (Ketorolacinj15mg1mlcarton)

Carton packaging label for Ketorolac Tromethamine Injection, USP 15 mg/mL by Camber Pharmaceuticals, Inc. The label indicates the product is for intravenous and intramuscular use and contains 25 single-dose vials of 1 mL each. The label includes manufacturer details for Aspiro Pharma Limited in India and Camber Pharmaceuticals in New Jersey, USA.*

FDA Label Image

Ketorolacinj15mg1mlvial (Ketorolacinj15mg1mlvial)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL in a 1 mL single-dose vial. This injection solution is indicated for intravenous and intramuscular use. The product is labeled by Camber Pharmaceuticals, Inc. and manufactured by Aspiro Pharma Limited, India. The label includes NDC 31722-305-01 and space for lot and expiration dates.*

FDA Label Image

Ketorolacinj30mg1mlcarton (Ketorolacinj30mg1mlcarton)

Flat packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL by Camber Pharmaceuticals, Inc. The label states it is for intravenous/intramuscular use and includes directions to dispense the Medication Guide to each patient. The package contains 25 single-dose 1 mL vials. The label includes storage information, manufacturer details, and a barcode.*

FDA Label Image

Ketorolacinj30mg1mlvial (Ketorolacinj30mg1mlvial)

Label for Ketorolac Tromethamine Injection, USP 30 mg/mL, 1 mL single-dose vial. The label indicates use for intravenous and intramuscular administration. Manufactured for Camber Pharmaceuticals, Inc., and produced by Aspiro Pharma Limited, India. Includes NDC 31722-306-01 and barcode.*

FDA Label Image

Ketorolacinj60mg2mlcarton (Ketorolacinj60mg2mlcarton)

Packaging label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) single-dose vials. The label indicates it is for intravenous and intramuscular use. The box contains 25 vials of 2 mL each. Manufactured for Camber Pharmaceuticals, Inc. and including manufacturing information for Asispro Pharma Limited in India. The label includes dosing, storage, and contact information with a barcode and NDC 31722-307-25.*

FDA Label Image

Ketorolacinj60mg2mlvial (Ketorolacinj60mg2mlvial)

Label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) in a 2 mL single-dose vial by Camber Pharmaceuticals, Inc. The label indicates it is for intravenous and intramuscular use. It includes an NDC code 31722-307-02, barcode, lot and expiration placeholders, and states manufacturing by Aspiro Pharma Limited, India.*

FDA Label Image

Ketorolactromethaminefigura1 (Ketorolactromethaminefigura1)

Chemical structure of ketorolac tromethamine, depicting the molecular arrangement of the active ingredient ketorolac combined with tromethamine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.